Risk Stratification for the Prediction of Overall Survival Could Assists Treatment Decision Making at the Diagnosis of Castration-Resistant Prostate Cancer – a Multicenter Collaborative Study in Japan.

This study aimed to assess whether the new risk stratification according to predictors for overall survival (OS) at the diagnosis of metastatic castration-resistant prostate cancer (mCRPC) could determine the treatment outcomes and assist the treatment decision making.